Results 1 to 10 of about 3,813 (143)

Implications of divergence of methionine adenosyltransferase in archaea [PDF]

open access: yesFEBS Open Bio, 2022
Methionine adenosyltransferase (MAT) catalyzes the biosynthesis of S‐adenosyl methionine from l‐methionine and ATP. MAT enzymes are ancient, believed to share a common ancestor, and are highly conserved in all three domains of life.
Bhanu Pratap Singh Chouhan   +4 more
doaj   +5 more sources

Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis [PDF]

open access: yesNature Communications, 2022
High methionine and S-adenosylmethionine serum levels are related with obesity. Here the authors show that knockdown of methionine adenosyltransferase by using antisense oligonucleotides provides beneficial effects in obesity and comorbidities.
Diego Sáenz de Urturi   +28 more
doaj   +2 more sources

Long-term prognosis of 35 patients with methionine adenosyltransferase deficiency based on newborn screening in China [PDF]

open access: yesFrontiers in Cell and Developmental Biology, 2023
Methionine adenosyltransferase deficiency (MATD) is a rare metabolic disorder caused by mono- or biallelic MAT1A mutations that are not yet well understood.
Fan Tong   +20 more
doaj   +2 more sources

Hypermethioninemia due to methionine adenosyltransferase I/III deficiency and brain damage [PDF]

open access: yesBMC Pediatrics
Background and objectives Methionine adenosyltransferase I/III deficiency used to be considered a relatively benign disease. This study aims to elucidate the clinical characteristics of methionine adenosyltransferase I/III deficiency patients with ...
Xue Ma   +15 more
doaj   +2 more sources

Methionine Adenosyltransferase 1A and S-Adenosylmethionine in Alcohol-Associated Liver Disease [PDF]

open access: yesAntioxidants
Alcohol-associated liver disease (ALD) is a leading cause of liver-related morbidity, mortality, and premature death worldwide. Its pathogenesis is complex and incompletely understood, with disrupted methionine metabolism as a key contributor.
Lucía Barbier-Torres   +3 more
doaj   +2 more sources

Depletion of mitochondrial methionine adenosyltransferase α1 triggers mitochondrial dysfunction in alcohol-associated liver disease [PDF]

open access: yesNature Communications, 2022
Lower activity of MATα1, which catalyzes the synthesis of the methyl donor S-adenosylmethionine, and mitochondrial dysfunction occur in alcohol-associated liver disease (ALD).
Lucía Barbier-Torres   +21 more
doaj   +2 more sources

Discovery of Potential Scaffolds for Methionine Adenosyltransferase 2A (MAT2A) Inhibitors: Virtual Screening, Synthesis, and Biological Evaluation [PDF]

open access: yesMolecules
The inhibition of methionine adenosyltransferase 2A (MAT2A) in cancers harboring deletions of the methylthioadenosine phosphorylase (MTAP) gene induces synthetic lethality, making it a highly compelling strategy in the pursuit of precision anticancer ...
Chunchun Qi   +5 more
doaj   +2 more sources

Mechanism and Inhibition of Human Methionine Adenosyltransferase 2A. [PDF]

open access: yesBiochemistry, 2021
S-Adenosyl-l-methionine (AdoMet) is synthesized by the MAT2A isozyme of methionine adenosyltransferase in most human tissues and in cancers. Its contribution to epigenetic control has made it a target for anticancer intervention. A recent kinetic isotope effect analysis of MAT2A demonstrated a loose nucleophilic transition state.
Niland CN   +3 more
europepmc   +3 more sources

Methionine Adenosyltransferase I/III Deficiency Detected by Newborn Screening. [PDF]

open access: yesGenes (Basel), 2022
Methionine adenosyltransferase I/III deficiency is an inborn error of metabolism due to mutations in the MAT1A gene. It is the most common cause of hypermethioninemia in newborn screening. Heterozygotes are often asymptomatic. In contrast, homozygous or compound heterozygous individuals can develop severe neurological symptoms.
Hübner V   +4 more
europepmc   +4 more sources

A novel role of secreted methionine adenosyltransferase α2 in colorectal liver metastases [PDF]

open access: yesJournal of Experimental & Clinical Cancer Research
Background Colorectal liver metastasis (CRLM) occurs frequently in patients with colorectal cancer (CRC). Methionine adenosyltransferase (MAT) catalyzes the formation of S-adenosylmethionine, the principal methyl donor. MAT1A (encodes MATα1) is expressed
Monica Justo   +12 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy